ZPBP
gene geneOn this page
Also known as SP38ZPBP1
Summary
ZPBP (zona pellucida binding protein, HGNC:15662) is a protein-coding gene on chromosome 7p12.2, encoding Zona pellucida-binding protein 1 (Q9BS86). Plays a role in acrosome compaction and sperm morphogenesis.
ZPBP is one of several proteins that are thought to participate in secondary binding between acrosome-reacted sperm and the egg-specific extracellular matrix, the zona pellucida (McLeskey et al., 1998 [PubMed 9378618]).
Source: NCBI Gene 11055 — RefSeq curated summary.
At a glance
- Gene–disease (curated): spermatogenic failure 66 (Limited, GenCC)
- GWAS associations: 11
- Clinical variants (ClinVar): 60 total — 1 pathogenic
- Phenotypes (HPO): 4
- MANE Select transcript:
NM_007009
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15662 |
| Approved symbol | ZPBP |
| Name | zona pellucida binding protein |
| Location | 7p12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SP38, ZPBP1 |
| Ensembl gene | ENSG00000042813 |
| Ensembl biotype | protein_coding |
| OMIM | 608498 |
| Entrez | 11055 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000046087, ENST00000413331, ENST00000419417, ENST00000450231, ENST00000465922, ENST00000491129, ENST00000903719, ENST00000903720
RefSeq mRNA: 2 — MANE Select: NM_007009
NM_001159878, NM_007009
CCDS: CCDS5509, CCDS55110
Canonical transcript exons
ENST00000046087 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000552558 | 50018240 | 50018316 |
| ENSE00000683041 | 50031092 | 50031310 |
| ENSE00000683043 | 50057989 | 50058141 |
| ENSE00001136073 | 50093068 | 50093246 |
| ENSE00001201739 | 49937441 | 49937622 |
| ENSE00003593251 | 49983342 | 49983519 |
| ENSE00003607850 | 50089629 | 50089709 |
| ENSE00003788825 | 50081774 | 50081899 |
Expression profiles
Bgee: expression breadth ubiquitous, 103 present calls, max score 97.84.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4188 / max 344.6289, expressed in 25 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 84096 | 0.3707 | 19 |
| 84097 | 0.0203 | 5 |
| 84094 | 0.0166 | 3 |
| 84095 | 0.0069 | 3 |
| 84093 | 0.0043 | 3 |
Top tissues by expression
251 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adult organism | UBERON:0007023 | 97.84 | gold quality |
| sperm | CL:0000019 | 97.65 | gold quality |
| left testis | UBERON:0004533 | 97.51 | gold quality |
| right testis | UBERON:0004534 | 97.29 | gold quality |
| male germ cell | CL:0000015 | 97.28 | gold quality |
| testis | UBERON:0000473 | 95.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.38 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.59 | gold quality |
| buccal mucosa cell | CL:0002336 | 61.22 | silver quality |
| islet of Langerhans | UBERON:0000006 | 58.49 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 55.82 | gold quality |
| cerebellar cortex | UBERON:0002129 | 55.77 | gold quality |
| cranial nerve II | UBERON:0000941 | 55.72 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 55.68 | gold quality |
| cerebellum | UBERON:0002037 | 54.77 | gold quality |
| tibialis anterior | UBERON:0001385 | 53.68 | silver quality |
| skin of hip | UBERON:0001554 | 53.65 | silver quality |
| cauda epididymis | UBERON:0004360 | 52.40 | gold quality |
| pancreatic ductal cell | CL:0002079 | 52.08 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 52.02 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.97 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 51.57 | gold quality |
| deltoid | UBERON:0001476 | 51.43 | gold quality |
| right uterine tube | UBERON:0001302 | 51.06 | gold quality |
| vastus lateralis | UBERON:0001379 | 50.81 | gold quality |
| frontal pole | UBERON:0002795 | 50.41 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| paraflocculus | UBERON:0005351 | 50.18 | gold quality |
| thymus | UBERON:0002370 | 50.04 | gold quality |
| caput epididymis | UBERON:0004358 | 50.04 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-180759 | yes | 313.01 |
| E-GEOD-134144 | yes | 31.97 |
| E-ANND-3 | yes | 4.52 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting ZPBP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-205-3P | 99.92 | 69.92 | 3165 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-497-3P | 99.61 | 69.71 | 1990 |
| HSA-MIR-2053 | 99.57 | 69.15 | 1635 |
| HSA-MIR-4427 | 99.34 | 70.33 | 1854 |
| HSA-MIR-181A-2-3P | 98.91 | 67.60 | 1168 |
Literature-anchored findings (GeneRIF, showing 2)
- Data show that loss of zona pellucida binding proteins 1 and 2 in the acrosomal matrix disrupts acrosome biogenesis and sperm morphogenesis. (PMID:17664285)
- Data suggest that missense mutations exert a dominant-negative effect due to altered ZPBP1 protein folding and protein:protein interactions in the acrosome. (PMID:21911476)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zpbp | ENSMUSG00000020193 |
| rattus_norvegicus | Zpbp | ENSRNOG00000027801 |
Paralogs (1): ZPBP2 (ENSG00000186075)
Protein
Protein identifiers
Zona pellucida-binding protein 1 — Q9BS86 (reviewed: Q9BS86)
Alternative names: Inner acrosomal membrane IAM38, Sp38
All UniProt accessions (3): C9JIS7, Q9BS86, F8WDW2
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in acrosome compaction and sperm morphogenesis. Is implicated in sperm-oocyte interaction during fertilization.
Subunit / interactions. Interacts with CFAP65.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Acrosome membrane. Secreted.
Tissue specificity. Expressed specifically in testis.
Post-translational modifications. N-glycosylated.
Disease relevance. Spermatogenic failure 66 (SPGF66) [MIM:619799] An autosomal recessive male infertility disorder characterized by globozoospermia. Affected individuals have a normal sperm count, but spermatozoa are round-headed and lack the acrosome. In addition to pure globozoospermia, some patients have a mixture of acrosomeless spermatozoa and spermatozoa with small or detached acrosomes, which is defined as acrosomal hypoplasia. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the zona pellucida-binding protein Sp38 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9BS86-1 | 1 | yes |
| Q9BS86-2 | 2 |
RefSeq proteins (2): NP_001153350, NP_008940* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007110 | Ig-like_dom | Domain |
| IPR010857 | Sp38-bd | Family |
| IPR013783 | Ig-like_fold | Homologous_superfamily |
| IPR036179 | Ig-like_dom_sf | Homologous_superfamily |
| IPR048805 | ZPBP1/2_C | Domain |
| IPR048806 | ZPBP1/2_N | Domain |
Pfam: PF07354, PF20626
UniProt features (15 total): sequence variant 8, glycosylation site 3, signal peptide 1, chain 1, sequence conflict 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BS86-F1 | 82.47 | 0.66 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (3): 114, 187, 340
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 100 (showing top):
GOBP_SINGLE_FERTILIZATION, GOCC_SECRETORY_GRANULE, GOBP_VESICLE_ORGANIZATION, GOBP_MALE_GAMETE_GENERATION, GOBP_SECRETORY_GRANULE_ORGANIZATION, GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, GOBP_SPERM_EGG_RECOGNITION, GOBP_ACROSOME_ASSEMBLY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GNF2_CCNA1, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_FERTILIZATION
GO Biological Process (2): acrosome assembly (GO:0001675), binding of sperm to zona pellucida (GO:0007339)
GO Molecular Function (0):
GO Cellular Component (7): acrosomal vesicle (GO:0001669), acrosomal membrane (GO:0002080), zona pellucida receptor complex (GO:0002199), extracellular region (GO:0005576), nucleus (GO:0005634), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| developmental process involved in reproduction | 1 |
| spermatid development | 1 |
| cellular component assembly involved in morphogenesis | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| secretory granule organization | 1 |
| organelle assembly | 1 |
| sperm-egg recognition | 1 |
| secretory granule | 1 |
| acrosomal vesicle | 1 |
| secretory granule membrane | 1 |
| chaperonin-containing T-complex | 1 |
| protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
866 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZPBP | SPA17 | Q15506 | 863 |
| ZPBP | SPACA1 | Q9HBV2 | 828 |
| ZPBP | DPY19L2 | Q6NUT2 | 818 |
| ZPBP | SPATA16 | Q9BXB7 | 789 |
| ZPBP | ABHD2 | P08910 | 689 |
| ZPBP | SPESP1 | Q6UW49 | 681 |
| ZPBP | GRB7 | Q14451 | 670 |
| ZPBP | ACRBP | Q8NEB7 | 649 |
| ZPBP | SPACDR | Q8IZ16 | 647 |
| ZPBP | IKZF3 | Q9UKT9 | 643 |
| ZPBP | GRB10 | Q13322 | 615 |
| ZPBP | ZAN | Q9Y493 | 589 |
| ZPBP | IKZF1 | Q13422 | 578 |
| ZPBP | SPACA3 | Q8IXA5 | 560 |
| ZPBP | ROPN1 | Q9HAT0 | 550 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZPBP | CALU | psi-mi:“MI:0915”(physical association) | 0.370 |
| TEX101 | GGT3P | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): ZPBP (Two-hybrid), ZPBP (Proximity Label-MS), ZPBP (Affinity Capture-MS), ZPBP (Two-hybrid)
ESM2 similar proteins: A0JNQ6, A2RT67, A2RUS2, A6NC42, A6NGQ2, A9X185, O75031, O75817, O94955, O95267, P50747, Q06VW1, Q0II25, Q0ZFW8, Q1RMS8, Q1RMZ1, Q29108, Q2TBA3, Q3T0J1, Q3TYS2, Q4VX76, Q568D5, Q568M3, Q587J7, Q5JSQ8, Q5T9G4, Q5ZLS2, Q62522, Q69ZK0, Q6AYA6, Q6P5G6, Q7Z7H3, Q80X86, Q86WV5, Q8BXK4, Q8C0Q9, Q8CHQ0, Q8TCU6, Q8WUE5, Q91Z62
Diamond homologs: Q29108, Q62522, Q6PVW7, Q6Q2W4, Q6X782, Q6X784, Q6X786, Q9BS86
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 35 |
| Likely benign | 14 |
| Benign | 6 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1344566 | NM_007009.3(ZPBP):c.931C>T (p.Gln311Ter) | Pathogenic |
SpliceAI
2539 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:49937621:CA:C | acceptor_gain | 1.0000 |
| 7:49937623:C:CC | acceptor_gain | 1.0000 |
| 7:49983341:CCA:C | donor_gain | 1.0000 |
| 7:50031307:TAAG:T | acceptor_gain | 1.0000 |
| 7:50031311:C:CC | acceptor_gain | 1.0000 |
| 7:50058142:C:CC | acceptor_gain | 1.0000 |
| 7:50080141:C:CT | donor_gain | 1.0000 |
| 7:50080142:T:TT | donor_gain | 1.0000 |
| 7:50089710:C:CC | acceptor_gain | 1.0000 |
| 7:50104407:GTACA:G | donor_gain | 1.0000 |
| 7:50104412:G:GG | donor_gain | 1.0000 |
| 7:49912123:G:GT | donor_gain | 0.9900 |
| 7:49937620:TCA:T | acceptor_gain | 0.9900 |
| 7:49937621:CAC:C | acceptor_gain | 0.9900 |
| 7:49937622:AC:A | acceptor_loss | 0.9900 |
| 7:49937624:T:G | acceptor_loss | 0.9900 |
| 7:49952878:AG:A | donor_gain | 0.9900 |
| 7:49983338:ATAC:A | donor_loss | 0.9900 |
| 7:49983339:T:TG | donor_loss | 0.9900 |
| 7:49983340:A:AC | donor_gain | 0.9900 |
| 7:49983340:ACCAC:A | donor_loss | 0.9900 |
| 7:49983341:C:CC | donor_gain | 0.9900 |
| 7:49983341:C:CT | donor_gain | 0.9900 |
| 7:49983484:T:C | acceptor_gain | 0.9900 |
| 7:50030359:A:C | donor_gain | 0.9900 |
| 7:50031085:GACTT:G | donor_loss | 0.9900 |
| 7:50031086:ACTTA:A | donor_loss | 0.9900 |
| 7:50031087:CTT:C | donor_loss | 0.9900 |
| 7:50031088:TTACC:T | donor_loss | 0.9900 |
| 7:50031089:T:TA | donor_loss | 0.9900 |
AlphaMissense
2264 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:50081802:C:A | W102C | 0.998 |
| 7:50081802:C:G | W102C | 0.998 |
| 7:50081804:A:G | W102R | 0.997 |
| 7:50081804:A:T | W102R | 0.997 |
| 7:50058056:A:C | C140W | 0.995 |
| 7:50081854:C:G | C85S | 0.995 |
| 7:50081855:A:G | C85R | 0.995 |
| 7:50081855:A:T | C85S | 0.995 |
| 7:49983398:C:G | C302S | 0.994 |
| 7:49983399:A:T | C302S | 0.994 |
| 7:50058058:A:G | C140R | 0.994 |
| 7:50058071:A:C | S135R | 0.994 |
| 7:50058071:A:T | S135R | 0.994 |
| 7:50058073:T:G | S135R | 0.994 |
| 7:49983399:A:G | C302R | 0.993 |
| 7:50081854:C:T | C85Y | 0.993 |
| 7:50081868:A:C | S80R | 0.993 |
| 7:50081868:A:T | S80R | 0.993 |
| 7:50081870:T:G | S80R | 0.993 |
| 7:49937616:C:G | C323S | 0.992 |
| 7:49937616:C:T | C323Y | 0.992 |
| 7:49937617:A:T | C323S | 0.992 |
| 7:49983397:G:C | C302W | 0.992 |
| 7:50031269:A:C | Y177D | 0.992 |
| 7:50058057:C:G | C140S | 0.992 |
| 7:50058057:C:T | C140Y | 0.992 |
| 7:50058058:A:T | C140S | 0.992 |
| 7:50081853:A:C | C85W | 0.992 |
| 7:49937615:G:C | C323W | 0.991 |
| 7:49937617:A:G | C323R | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000000584 (7:50094801 T>C), RS1000012260 (7:49949496 A>C), RS1000018716 (7:49882754 T>C), RS1000023447 (7:49929704 G>A), RS1000028091 (7:49996821 C>T), RS1000057468 (7:49903993 A>G), RS1000062416 (7:49841043 A>C), RS1000089037 (7:49967973 C>A,G,T), RS1000091225 (7:49973763 G>A), RS1000125961 (7:50059090 T>C), RS1000142679 (7:49897190 C>T), RS1000146899 (7:49917721 T>C,G), RS1000152848 (7:50059167 T>C), RS1000157808 (7:50015389 T>C), RS1000186590 (7:49869752 C>A)
Disease associations
OMIM: gene MIM:608498 | disease phenotypes: MIM:619799
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| spermatogenic failure 66 | Limited | Unknown |
Mondo (1): spermatogenic failure 66 (MONDO:0030716)
Orphanet (0):
HPO phenotypes
4 total (4 of 4 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0012205 | Globozoospermia |
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000879_33 | Crohn’s disease | 1.000000e-08 |
| GCST000892_4 | Total ventricular volume (Alzheimer’s disease interaction) | 9.000000e-06 |
| GCST001725_93 | Inflammatory bowel disease | 7.000000e-15 |
| GCST004131_94 | Inflammatory bowel disease | 5.000000e-11 |
| GCST004132_57 | Crohn’s disease | 9.000000e-12 |
| GCST005950_9 | Body mass index x sex x age interaction (4df test) | 2.000000e-09 |
| GCST005951_200 | Body mass index | 2.000000e-08 |
| GCST005951_57 | Body mass index | 3.000000e-10 |
| GCST005953_3 | Body mass index (age <50) | 8.000000e-10 |
| GCST009391_1696 | Metabolite levels | 5.000000e-06 |
| GCST90002382_370 | Eosinophil percentage of white cells | 4.000000e-14 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
| EFO:0010344 | cholesteryl ester 18:1 measurement |
| EFO:0007991 | eosinophil percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| arsenite | increases methylation | 1 |
| sodium arsenite | affects methylation | 1 |
| pentanal | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation, affects methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: spermatogenic failure 66
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 66